Home › NDC Lookup › RxCUI directory › RxCUI 903694

1 ML liothyronine sodium 0.01 MG/ML Injection — RxCUI 903694

RxNorm drug concept · Semantic clinical drug
RxCUI 903694 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI903694
Official name1 ML liothyronine sodium 0.01 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asliothyronine sodium 10 MCG per 1 ML Injection; liothyronine sodium 10 MCG in 1 ML Injection; liothyronine sodium 0.01 MG per 1 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Liothyronine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Both are thyroid hormone replacements, but they're not the same thing. Levothyroxine is T4, a hormone your body has to convert into the active form (T3) before it can be used. Liot...
  • What exactly is liothyronine, and how is it different from levothyroxine?
  • No — and this is actually a boxed warning on the label. If your thyroid levels are already normal, liothyronine won't meaningfully help you lose weight. Taking doses high enough to...
  • I've heard people use thyroid hormone to lose weight. Is that safe?
📖 Read our full Liothyronine guide →

🕸️ Concept Web — How 1 ML liothyronine sodium 0.01 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML liothyronine sodium 0.01 MG/ML Injection RxCUI 903694

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Liothyronine 10814
    • Liothyronine sodium 142448
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Liothyronine Injection 1867723
    • Liothyronine sodium Injection 2649004
    • Liothyronine Injectable Product 1158805
    • Liothyronine sodium Injectable Product 2662521
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Liothyronine sodium 0.01 MG/ML 903693

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Liothyronine sodium 0.01 MG/ML SCDC · 903693
  • Liothyronine Injection SCDF · 1867723
  • Liothyronine sodium Injection SCDFP · 2649004
  • Liothyronine Injectable Product SCDG · 1158805
  • Liothyronine sodium Injectable Product SCDGP · 2662521

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 903694 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
39822-0151-01 1 VIAL in 1 CARTON (39822-0151-1) / 1 mL in 1 VIAL Liothyronine Sodium XGen Pharmaceuticals DJB, Inc. 2005-08-17
Observed labelers: XGen Pharmaceuticals DJB, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.